4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-018526
Chief Commercial Officer sold 15,262 shares at $4.40 ($67,167)
From the SEC's structured data for this filing
Trades in this filing
VAN BEEK JEROEN B · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-17 | Sale : show line 1 in the form | −15,262 | $4.40 | $67,167 | 389,526 | D |
| Open-market sales · 15,262 sh · avg $4.40 · $67,167 | ||||||
Loading xslF345X03/doc4.xml…